- Acumen Powered by Robins Kaplan LLP™
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
Acumen Powered by Robins Kaplan LLPTM
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 15, 2021Jennifer Leland Named President of the Women Lawyers Association of Los Angeles Foundation
-
September 15, 2021Roman Silberfeld Named to Annual List of Top 100 Attorneys in California
-
September 14, 2021Robins Kaplan Increases Starting Associate Salaries to $180,000
-
September 18, 20212021 Walk Like MADD Minnesota
-
September 18, 2021Page Education Foundation 2021 Justice Gala
-
September 21, 2021USC Gould School of Law 2021 Intellectual Property Institute
-
August 26, 2021Briefly: Motions for judicial notice in the 8th Circuit
-
Summer 2021Robins Kaplan Blocks Effort by Juul and Altria to Sidestep Blame for Minnesota’s Youth Vaping Epidemic
-
Summer 2021The Chauvin Case:
A Lifting of the Veil or Only a Peek Behind the Curtain? -
September 16, 2021Financial Daily Dose 9.16.2021 | Top Story: White House Discusses Vax Mandates With Business Leaders
-
September 15, 2021Financial Daily Dose 9.15.2021 | Top Story: CPI Shows Slowing Price Increases in August
-
September 15, 2021Protecting Your Trade Secrets: Trust but Verify
Eric Lindenfeld Joins Robins Kaplan's Mass Tort Group
March 24, 2017
Robins Kaplan LLP recently welcomed Eric Lindenfeld to the firm’s Mass Tort Group, where he focuses his practice on representing individuals who have been harmed by defective pharmaceutical and medical device products. Lindenfeld has experience in all phases of mass tort litigation, including trial practice, motion practice, conducting depositions, and written discovery. He is admitted to practice in Minnesota and in the U.S. District Court, District of Minnesota.
Lindenfeld earned his law degree, with honors, from the University of Minnesota. While attending law school, he won awards for outstanding written advocacy in various moot court competitions. He has also authored several scholarly articles on cutting-edge and developing topics in mass tort litigation.
Lindenfeld’s publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology and the Food and Drug Administration casebooks.
Related Professionals
Eric M. Lindenfeld
Associate
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.